What is the high-dose influenza vaccine that contains eggs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

High-Dose Influenza Vaccine for Patients ≥65 Years with Egg Allergy

For patients aged 65 years or older with a history of mild egg allergy (hives only), Fluzone High-Dose is an acceptable option and can be safely administered. 1

Understanding the Vaccine and Egg Content

Fluzone High-Dose is an egg-based, high-dose trivalent inactivated influenza vaccine (HD-IIV3) that contains 60 μg of hemagglutinin per strain—four times the amount in standard-dose vaccines. 1, 2 Like most inactivated influenza vaccines, it is manufactured via propagation of virus in eggs and therefore contains residual egg protein. 1

Current Guidance for Egg Allergy

The Advisory Committee on Immunization Practices (ACIP) has evolved its recommendations regarding egg allergy:

  • All persons aged ≥6 months with egg allergy should receive influenza vaccine, and any influenza vaccine (egg-based or non-egg-based) that is otherwise appropriate for the recipient's age and health status can be used. 1

  • For patients with mild egg allergy (specifically those who have experienced only hives following egg exposure), egg-based vaccines including Fluzone High-Dose can be administered without special precautions. 1

  • The only absolute contraindication is a history of severe allergic reaction (anaphylaxis) to eggs or any vaccine component. 1

Why High-Dose for Patients ≥65 Years

ACIP now expresses a preferential recommendation for higher-dose or adjuvanted influenza vaccines in adults aged 65 years and older. 3, 4 The evidence supporting this includes:

  • Fluzone High-Dose demonstrated 24.2% relative efficacy over standard-dose vaccine in preventing laboratory-confirmed influenza in a randomized trial of 31,989 persons aged ≥65 years. 3

  • High-dose vaccine consistently reduces hospitalizations for pneumonia, influenza, cardiorespiratory illnesses, and mortality in elderly populations. 3

  • The vaccine elicits higher hemagglutination inhibition (HAI) titers against all three influenza virus strains compared to standard-dose vaccines in older adults. 1, 3

Administration Protocol

  • Fluzone High-Dose is administered as a single 0.5 mL intramuscular injection in the deltoid muscle. 1, 3

  • Only one dose per influenza season is required. 3

  • The vaccine is available as a prefilled syringe with no mercury content. 1

Alternative Options if Egg Allergy is Severe

If the patient has a history of anaphylaxis to eggs (not just hives):

  • Consider Flublok (recombinant influenza vaccine, RIV3), which is manufactured without eggs and contains no egg protein. 1 However, this vaccine is only approved for ages 18-49 years in older guidelines 1, though newer formulations may have expanded age indications.

  • Flucelvax (cell culture-based vaccine) contains minimal egg protein (<50 femtograms) but cannot be considered completely egg-free and should be used with caution. 1

Common Pitfalls to Avoid

  • Do not delay vaccination to obtain a specific product when an appropriate one is available. 5 If high-dose vaccine is temporarily unavailable, standard-dose vaccine should be administered. 3

  • Do not confuse high-dose with standard-dose formulations—verify the product is specifically labeled "Fluzone High-Dose" with 60 μg hemagglutinin per strain. 3

  • Patients may experience more frequent injection site reactions and systemic symptoms with high-dose vaccine compared to standard-dose, but these are typically mild and transient. 1, 3

  • Avoid vaccinating in July or August for most adults ≥65 years due to concerns about waning immunity before peak influenza season. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Fluzone® High-Dose Influenza Vaccine.

Expert review of vaccines, 2016

Guideline

High-Dose Influenza Vaccine Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Influenza Vaccine Availability and Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.